These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1424770)

  • 21. [Activation mechanism and reaction process of the complement system--the alternative pathway].
    Konno T; Shibaki H
    Nihon Rinsho; 1979 May; 37(5):956-62. PubMed ID: 381726
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP; Wattre P; Santoro F; Capron A
    Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
    [No Abstract]   [Full Text] [Related]  

  • 23. Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.
    Ezekowitz RA; Sim RB; Hill M; Gordon S
    J Exp Med; 1984 Jan; 159(1):244-60. PubMed ID: 6319531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary therapies for inflammation.
    Wang Y
    Nat Biotechnol; 2006 Oct; 24(10):1224-6. PubMed ID: 17033658
    [No Abstract]   [Full Text] [Related]  

  • 25. [Protein chemistry of the complement system].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
    [No Abstract]   [Full Text] [Related]  

  • 26. Terminal complement without C5 convertase?
    Roumenina LT
    Blood; 2021 Jan; 137(4):431-432. PubMed ID: 33507301
    [No Abstract]   [Full Text] [Related]  

  • 27. [Functions and structure of complement inactivators in membrane proteins. 2). Decay-accelerating factor].
    Sugita Y
    Nihon Rinsho; 1988 Sep; 46(9):1927-32. PubMed ID: 2468004
    [No Abstract]   [Full Text] [Related]  

  • 28. The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?
    Harrison RA
    Semin Immunopathol; 2018 Jan; 40(1):15-35. PubMed ID: 29167939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional properties of membrane cofactor protein of complement.
    Seya T; Atkinson JP
    Biochem J; 1989 Dec; 264(2):581-8. PubMed ID: 2481448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Complement, a system of recognition of activation and amplification].
    Peltier AP; Kazatchkine MD
    Ann Immunol (Paris); 1982; 133C(2):149-54. PubMed ID: 6921958
    [No Abstract]   [Full Text] [Related]  

  • 32. Staphylococcal complement evasion by various convertase-blocking molecules.
    Jongerius I; Köhl J; Pandey MK; Ruyken M; van Kessel KP; van Strijp JA; Rooijakkers SH
    J Exp Med; 2007 Oct; 204(10):2461-71. PubMed ID: 17893203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
    J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J; Lesavre P
    Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
    [No Abstract]   [Full Text] [Related]  

  • 37. The C3/C5 convertase of the alternative pathway of complement: stabilization and restriction of control by lanthanide ions.
    Fishelson Z; Müller-Eberhard HJ
    Mol Immunol; 1983 Mar; 20(3):309-15. PubMed ID: 6553181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
    Rimoldi MT; Sher A; Heiny S; Lituchy A; Hammer CH; Joiner K
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):193-7. PubMed ID: 3277170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress on complement protein chemistry and the molecular mechanism of activation. Alternative complement pathway].
    Kinoshita T
    Nihon Rinsho; 1988 Sep; 46(9):1894-8. PubMed ID: 3241383
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Parker CJ; Baker PJ; Rosse WF
    J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.